IOMAI CORPORATION
Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called transcutaneous immunization (TCI). TCI taps into the unique benefits of a major group of antigen-presenting cells found in the outer layers of the skin to generate an enhanced immune response. Iomai is leveraging TCI to enhance the efficacy of existing vaccines, enable new vaccines that are viable only through transcutaneous administration and expand the global ... vaccine market. The company was incorporated in 1997 and is based in Gaithersburg, Maryland. Intercell USA, Inc. was formerly known as Iomai Corporation. As a result of the acquisition of Iomai Corporation by Intercell Ag, Iomai Corporation's name was changed. As of August 5, 2008, Intercell USA, Inc. operates as a subsidiary of Intercell Biomedical Research & Development AG.
IOMAI CORPORATION
Industry:
Biotechnology Health Care Medical
Founded:
1997-01-01
Address:
Gaithersburg, Maryland, United States
Country:
United States
Website Url:
http://www.iomai.com
Total Employee:
51+
Status:
Active
Contact:
(301)556-4500
Total Funding:
54 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt IPv6 Cloudflare Cloudflare Hosting Cloudflare Network Error Logging Cloudflare DNS
Current Advisors List
Current Employees Featured
Investors List
Essex Woodlands Healthcare Partners
Essex Woodlands Healthcare Partners investment in Series C - Iomai Corporation
China Development Industrial Bank (CDIB)
China Development Industrial Bank (CDIB) investment in Series C - Iomai Corporation
Domain Associates
Domain Associates investment in Series C - Iomai Corporation
Technology Partners
Technology Partners investment in Series C - Iomai Corporation
MedImmune Ventures
MedImmune Ventures investment in Series C - Iomai Corporation
SAM Private Equity
SAM Private Equity investment in Series C - Iomai Corporation
ProQuest Investments
ProQuest Investments investment in Series C - Iomai Corporation
New Enterprise Associates
New Enterprise Associates investment in Series C - Iomai Corporation
Official Site Inspections
http://www.iomai.com
- Host name: 104.21.28.20
- IP address: 104.21.28.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Iomai Corporation"
Iomai Corporation - Crunchbase Company Profile & Funding
Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called View contacts for Iomai Corporation to access new …See details»
Iomai Corporation Management Team | Org Chart - RocketReach
The Iomai Corporation management team includes Richard Kenney (Vice President, Clinical Development), Gregory Glenn (Chief Scientific Officer), and Julia Chung (Dir, Data …See details»
IOMAI - Wikipedia
IOMAI was a Biotech company founded in 1997 by Gregory Glenn M.D. of the Walter Reed Army Institute of Research and Dean Lewis, a World Bank employee. The company was the first to develop the concept of transcutaneous immunization, delivery of vaccines to the skin using a patch or similar method. This provided a means to stimulate robust immune responses safely as the skin patch-based immunization targeted Langerhans cells in the skin. The patch technology …See details»
Iomai Company Profile 2024: Valuation, Investors, Acquisition
Iomai General Information Description. Developer of vaccines and immune system stimulants. The company is focused on discovering and developing vaccines and immune system …See details»
Iomai Corporation - Products, Competitors, Financials, Employees ...
Iomai Corporation was founded in 1997. Where is Iomai Corporation's headquarters? Iomai Corporation's headquarters is located at 20 Firstfield Road, Gaithersburg. What is Iomai …See details»
Iomai Corporation - Contacts, Employees, Board Members
Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called. Search Crunchbase. Start Free Trial . Chrome …See details»
Iomai Corporation - Company Profile - Tracxn
Apr 28, 2024 Iomai Corporation - Vaccine and Immune system stimulants. Acquired by Intercell. Raised a total funding of $54M over 1 round from 10 investors. Iomai Corporation has 347 …See details»
Intercell - Overview, News & Similar companies | ZoomInfo.com
Intercell contact info: Phone number: (301) 556-4500 Website: www.iomai.com What does Intercell do? Intercell AG was a biotechnology company based in Vienna which focused on the …See details»
Iomai Corporation - Tech Stack, Apps, Patents & Trademarks
Nov 1, 2024 Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology calledSee details»
iomai.com - Whois.com
Whois Lookup for iomai.com. Domain Services Transfer your Domain Consolidate your domains quickly & easily Free With Every Domain Get over $100 worth of free servicesSee details»
Working At Iomai Corporation: Company Overview and Culture
Zippia gives an in-depth look into the details of Iomai Corporation, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Iomai Corporation. …See details»
Intercell AG closes Acquisition of Iomai Corporation - SEC.gov
Intercell AG (“Intercell”) closes the previously announced acquisition of Iomai Corporation (“Iomai”) for a total consideration of 1,442,819 Intercell shares and a cash component of EUR …See details»
Intercell AG to Acquire Iomai Corporation to Expand Late Stage …
May 12, 2008 Under the terms of the merger agreement, Intercell will acquire Iomai for USD 6.60 per share of Iomai's common stock representing a fully diluted equity value of Iomai of …See details»
Intercell USA, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Iomai is leveraging TCI to enhance the efficacy of existing vaccines, develop new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. …See details»
Iomai Corporation - Crunchbase
Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology calledSee details»
Iomai Corp. Nanomaterials - Nano Orbit
Iomai is leveraging TCI to enhance the efficacy of existing vaccines, enable new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. We …See details»
Intercell snaps up Iomai in $189M deal
May 13, 2008 The little Maryland-based vaccine developer Iomai, which has posted some impressive data on a new therapy for traveler's diarrhea as well as an adjuvant for bird flu …See details»
Iomai Corporation - Funding, Financials, Valuation & Investors
Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called. Search Crunchbase. ... How much funding has this …See details»
Ioami Dissertation Writing Help Online
Iomai.com. Home; Topics; Get Advice; Preparing Tips; Style; Structure; Twitter; Facebook; Google+; ultimate guides for excellent dissertation writing Solution Number One - Get …See details»
The Michaels Organization
Cookies are used on this site to assist in continually improving the candidate experience and all the interaction data we store of our visitors is anonymous.See details»